logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

 


Incyte Corporation Skyrockets on Promising Trial for Jakafi

  +Follow August 21, 2013 9:20AM
Share:
Tickers Mentioned:

Pharmaceutical company Incyte Corporation (INCY) released very positive news on Aug. 21, revealing that their pancreatic cancer treatment drug ruxolitinib, marketed under the trade name Jakafi, had performed very well in Phase II trials, and that the drug could now move on to Phase III.

Incyte Executive Vice President Richard S. Levy pointed out that sufferers from advanced pancreatic cancer currently have very few options. If approved, the orally-administered drug would be one of the first on the market that exists as "an attractive treatment option" for sufferers of pancreatic cancer.

If approved by the FDA, this would be a major breakthrough. Metastatic pancreatic cancer has the lowest survival rate of any form of cancer. Currently, less than one percent of people afflicted survive more than five years.

Jakafi's ability to increase lifespan for sufferers looks very promising. In the Phase II trials, the six month survival rate for patients (when coupled with chemotherapy treatment) for Jakafi was 42 percent, compared to 11 percent for patients on a placebo.

Jakafi was first approved by the Food and Drug Administration in 2011 to treat a bone marrow disease. After its success in that arena, the company specualted that the drug might effectively treat other types of cancer as well. Now, the drug is fast aproaching approval to treat pancreatic cancer as well. Though it is currently the only drug the company has gotten passed by the USFDA. Jakafi seems to be fulfilling early analyst speculation that it could be a billion dollar blockbuster drug for the Delaware-based drug maker.

Incyte earned $54.1 million from sales of Jakafi in the second quarter of 2013, and expects to earn between $220 and $230 million total this year.

Incyte rocketed on the news, and went up 29.19 percent to hit $34.88 a share. They’re up 58.82 percent on the year.

(image courtesy of Wikimedia commons)

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Signup for our daily newsletter and get our best articles emailed right to you!

Results for INCY
Krishna
3 Jul 15 19:08:00
RT @dougheuringaria: LR JULY 2015 HEALTHCARE CALENDAR OF EVENTS $CLVS $EPZM $CELG $INCY $IBB http://t.co/fPYm5ACYfl
Don H
3 Jul 15 17:24:33
RT @dougheuringaria: LR JULY 2015 HEALTHCARE CALENDAR OF EVENTS $CLVS $EPZM $CELG $INCY $IBB http://t.co/fPYm5ACYfl
Capital Market Labs
3 Jul 15 17:04:26
$INCY Trade Card -> http://t.co/Ud2tdPUSyR http://t.co/n8J8BGj2PM
Biotech Supernova
3 Jul 15 15:47:38
RT @dougheuringaria: LR JULY 2015 HEALTHCARE CALENDAR OF EVENTS $CLVS $EPZM $CELG $INCY $IBB http://t.co/fPYm5ACYfl
Michael Kieffer
3 Jul 15 15:46:56
RT @dougheuringaria: LR JULY 2015 HEALTHCARE CALENDAR OF EVENTS $CLVS $EPZM $CELG $INCY $IBB http://t.co/fPYm5ACYfl
Woll Street
3 Jul 15 15:21:34
RT @dougheuringaria: LR JULY 2015 HEALTHCARE CALENDAR OF EVENTS $CLVS $EPZM $CELG $INCY $IBB http://t.co/fPYm5ACYfl
WhiteCoatMafia
3 Jul 15 15:19:50
@jligas @SneakyPHolsters @bio_stock $INCY gets 100% in U.S. & 17-25% ish royalties for non-US. http://t.co/bLN1N8apXg http://t.co/xf4Go2mgjT
NT
3 Jul 15 12:55:43
RT @dougheuringaria: LR JULY 2015 HEALTHCARE CALENDAR OF EVENTS $CLVS $EPZM $CELG $INCY $IBB http://t.co/fPYm5ACYfl
WhiteCoatMafia
3 Jul 15 12:38:33
@jligas You can't accurately compare $INCY current market cap and $GERN market right after phase 2. https://t.co/a1N4tx9qIr
SkyTides
3 Jul 15 12:38:31
RT @dougheuringaria: LR JULY 2015 HEALTHCARE CALENDAR OF EVENTS $CLVS $EPZM $CELG $INCY $IBB http://t.co/fPYm5ACYfl
WhiteCoatMafia
3 Jul 15 12:18:20
@jligas Simple $GERN to $INCY or $PCYC comparisons are not accurate. See pic. Aug 2013 = some Jakafi phase 2 data. http://t.co/62HKrDIN2t
DAILYALERTS
3 Jul 15 11:00:16
$INCY Green inside bar on monthly chart, about 7.5% upside to recent high. $XLV $XBI $IBB http://t.co/EIo6H7fCDM
HumbleBioTrader
3 Jul 15 10:43:10
RT @dougheuringaria: LR JULY 2015 HEALTHCARE CALENDAR OF EVENTS $CLVS $EPZM $CELG $INCY $IBB http://t.co/fPYm5ACYfl
Anthony DePaola
3 Jul 15 10:40:41
RT @dougheuringaria: LR JULY 2015 HEALTHCARE CALENDAR OF EVENTS $CLVS $EPZM $CELG $INCY $IBB http://t.co/fPYm5ACYfl
dougheuring
3 Jul 15 10:39:52
LR JULY 2015 HEALTHCARE CALENDAR OF EVENTS $CLVS $EPZM $CELG $INCY $IBB http://t.co/fPYm5ACYfl
InvestWithConf
3 Jul 15 10:38:02
$INCY is rated BUY, 9.3% upside by Wall Street analysts based on average ratings/targets http://t.co/X6z5BWCxcs http://t.co/JfCYzdGsjf
Jason Ligas
3 Jul 15 10:37:51
@WhiteCoatMafia @SneakyPHolsters @bio_stock $INCY partnered too by the way.
Jason Ligas
3 Jul 15 10:36:52
@WhiteCoatMafia @SneakyPHolsters @bio_stock so even though $INCY has one approved drug for MF, $GERN will only be 1/18 of their market cap?
nixon786
3 Jul 15 08:37:13
@redacre @JacobPlieth @AlpineBV_Miller was so angry when I said $YMI should do head 2 head trial with $INCY agent that he wanted to punch
WKRB News
3 Jul 15 08:17:30
Zacks Lowers Incyte to Sell $INCY http://t.co/EwUAJ3amAo
Breaking News
3 Jul 15 08:11:04
$INCY: Zacks Lowers Incyte to Sell (INCY): http://t.co/hCEdtcKZkP
ProVesting
3 Jul 15 02:54:02
$ABEV $INCY: Trending Tickers: Ambev S.A. (NYSE:ABEV), The Western Union ...: http://t.co/de1Pyqgy5l
HS Stock Trader
2 Jul 15 16:01:55
#ONCI $ONCI will run hard next week! $ARGS $VUZI $EAC $BIND $LLTC $FWM $ISM $IRCP $CGNX $INCY $LMIA $FENX $NUTR $CACB $ANDE $DISH
BNK Invest
2 Jul 15 13:52:46
Incyte Moves Up In Market Cap Rank, Passing Hess $INCY $HES #stocks http://t.co/EIvSdA2IFA
Briefing.com
2 Jul 15 13:03:02
50 of the most #liquid high #RelativeStrength #stocks $AMZN $CRM $CYBR $INCY $QRVO $WUBA http://t.co/XJZZIy9HKU #LiquidMomentum
Market Int Center
2 Jul 15 12:01:36
Incyte $INCY Showing Neutral Technicals With Support At $100.80 ( http://t.co/SF91a9QGcw )
DailyStockPicks
2 Jul 15 08:33:57
$NVDA acquiring TransGaming Assets, values $TNSGF $TNG.V at 300%+ upside, 25 cents $CERN $NU $INCY investors read http://t.co/M6ATjY2Anp
The Legacy News
2 Jul 15 07:13:26
Incyte Stock Rating Lowered by Zacks $INCY http://t.co/WUWl1cHfaL
StockNewsWires
2 Jul 15 06:50:02
$INCY: Analyst Price Target Update on Incyte Corporation: http://t.co/CF8mejXdvf
BoardCentral
2 Jul 15 06:30:03
$INCY "Investigational New Drug Application for Phase 2 Study of ADXS-HPV" on Yahoo! Finance message boards: http://t.co/WETXDyYHsh
John W. Green JW
1 Jul 15 14:08:05
RT @Briefingcom: 50 of the most #liquid high #RelativeStrength #stocks $AMZN $CRM $CYBR $INCY $QRVO $WUBA http://t.co/XJZZIy9HKU #LiquidMom…
Shimon Blumenfeld
1 Jul 15 14:05:54
RT @Briefingcom: 50 of the most #liquid high #RelativeStrength #stocks $AMZN $CRM $CYBR $INCY $QRVO $WUBA http://t.co/XJZZIy9HKU #LiquidMom…
Briefing.com
1 Jul 15 14:03:04
50 of the most #liquid high #RelativeStrength #stocks $AMZN $CRM $CYBR $INCY $QRVO $WUBA http://t.co/XJZZIy9HKU #LiquidMomentum
Dakota Financial
1 Jul 15 13:20:17
Incyte Lowered to “Sell” at Zacks $INCY http://t.co/rf7GRtSuQg
SMPH #Sanders2016
1 Jul 15 13:06:28
$INCY received a new alert. Find out why at http://t.co/DySPCulznQ #stocks #daytrading #trading #mkt #NYSE #NAS… http://t.co/mWqUw11a7O
Sleek Money
1 Jul 15 13:06:05
Incyte Cut to Sell at Zacks $INCY http://t.co/8u8Ih3ZPnu
US Consumer News
1 Jul 15 13:03:40
Incyte downgraded by Zacks to sell. http://t.co/q8S7nRQj3p $INCY #INCY
Media Sentiment
1 Jul 15 13:03:23
$INCY received a new alert. Find out why at http://t.co/nZwqReM0tj #stocks #daytrading #trading #mkt #NYSE #NASDAQ #markets 350
MarketBeatCom
1 Jul 15 13:01:38
Incyte downgraded by Zacks to sell. http://t.co/ZVJ1JGEys6 $INCY #INCY
Ticker Report
1 Jul 15 12:57:37
Incyte Cut to Sell at Zacks $INCY http://t.co/m90vrUVahz
StockNewsWires
1 Jul 15 07:44:02
$INCY: Momentum Stock in Focus: Incyte Corporation (NASDAQ:INCY): http://t.co/4UENF6omqv
$teph
1 Jul 15 04:52:05
Watching Long. $RMBS $OXM $RAD $SYK $LEA $CFG $INCY $BK $LYV $HMHC $BBT $CME $FULT $HBAN $MMC $RSP $SCHW $UNM $VOO $VOYA
Capital Market Labs
1 Jul 15 03:45:54
$INCY Trade Card -> http://t.co/Ud2tdPUSyR http://t.co/9TNyPthPj4
MarketBeatCom
30 Jun 15 15:38:31
Want automatic email alerts for $ACAS $LNN $ITT $CPA $INCY? Subscribe to MarketBeat Daily http://t.co/nSJuDsYidj
Briefing.com
30 Jun 15 14:33:02
50 of the most #liquid high #RelativeStrength #stocks $AMZN $CRM $CYBR $INCY $QRVO $WUBA http://t.co/XJZZIy9HKU #LiquidMomentum
usasingh11
30 Jun 15 13:23:01
$PCYC $INCY $GEVA I missed but I don't want to miss next Baker Bros HIdden gem $IDRA . Long in Roth almost 1 year @HedgeMind @bret_jensen
Market Int Center
30 Jun 15 12:39:08
Incyte $INCY Trading Near $105.95 Resistance Level ( http://t.co/THxDmOykSx )
BioInvestor
30 Jun 15 08:24:32
@mstrbass2000 $Blrx is a TEVA Spin off !! $BLRX a small cap Stock turns into a Big Blue Chip ! $CPRX $ORMP $TKRM $INO $Incy
Breaking News Now
30 Jun 15 05:49:02
$HPQ $INCY: Stocks in News: Twenty-First Century Fox, Inc. (NASDAQ:FOXA ...: http://t.co/qhW3sQFob7
InvestWithConf
30 Jun 15 05:02:02
$INCY is rated BUY, 14.5% upside by Wall Street analysts based on average ratings/targets http://t.co/X6z5BWCxcs http://t.co/Zull4CmNMu
				
				
  +Follow August 21, 2013 9:20AM
Share:

Comments

 

blog comments powered by Disqus

 

 Today's Must Reads

Microsegmentation: The Future of Cybersecurity?


How this Playboy Playmate Became a Better Stock Trader Than You

Long Term Rates Are On The Up…What’s Next?

The Modern Web: So Many Ways to Invest in Wireless Mobile Stocks

It's Time for the Rest of the Country to Legalize Weed

 

Do you expect a 10% correction by the end of 2015? in Equities.com Polls on LockerDome

About us

Equities.com is an advanced financial data portal and social network designed to connect self-directed investors with the world’s most innovative startup and small cap companies. Through our in-depth coverage of small cap markets, comprehensive research and stock valuation reports, state of the art issuer products, and world class events, Equities.com provides the social tools and insight that drive tomorrow’s investment relationships and opportunities.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.

Login or Register

LOG IN